DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 482 participants.
Also called NCT03334630
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 482 participants
- Registry
-
NCT03334630
-
- Other papers using this trial's data
- A Novel Temperature-Controlled Radiofrequency Catheter Ablation System Used to Treat Patients With Paroxysmal Atrial Fibrillation
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Czechia, France, Italy
- Registry status
- Completed
Technical summary
Registry record NCT03334630. Randomized; single masking; primary purpose treatment. Start 2017-11-06 (actual); primary completion 2019-11-18 (actual). Results posted on 2020-12-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation
- Acronym
- DIAMOND-AF
- Condition
- Paroxysmal Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Intervention (Device)
- DiamondTemp Ablation catheter
- Intervention (Device)
- TactiCath Quartz Ablation catheter
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
Record details
- Record id
cardio:ct-nct03334630- Content hash
e7371b53cb59011718c4ee173f0596525d44e37ba6c3d91f30f2681de0598652